Published in Lancet on March 02, 1991
Epidemiology of nosocomial fungal infections. Clin Microbiol Rev (1996) 5.03
Yeasts in the gut: from commensals to infectious agents. Dtsch Arztebl Int (2009) 3.08
The role of faecal Candida albicans in the pathogenesis of food-intolerant irritable bowel syndrome. Postgrad Med J (1992) 1.41
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics. Pharmaceuticals (Basel) (2013) 0.98
Fatal ulcerative panenteritis following colectomy in a patient with ulcerative colitis. Dig Dis Sci (1999) 0.94
The native microbiome of the nematode Caenorhabditis elegans: gateway to a new host-microbiome model. BMC Biol (2016) 0.92
Methods for detection of an intestinal secretory immunoglobulin A response to Candida spp. and their preliminary application in human immunodeficiency virus-infected patients with chronic diarrhea. Clin Diagn Lab Immunol (1995) 0.80
Antimicrobial effectors in the nematode Caenorhabditis elegans: an outgroup to the Arthropoda. Philos Trans R Soc Lond B Biol Sci (2016) 0.80
Elevated fecal Candida counts in patients with antibiotic-associated diarrhea: role of soluble fecal substances. Clin Diagn Lab Immunol (2003) 0.77
Faecal candida and diarrhoea. Arch Dis Child (2001) 0.76
Antibiotic-associated diarrhoea. Lancet (1991) 0.75
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrob Agents Chemother (1997) 7.07
Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med (1993) 6.12
Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med (1986) 5.83
Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet (1994) 5.73
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA (1998) 5.20
Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms. Antimicrob Agents Chemother (1976) 4.55
Multiple mechanisms of methicillin resistance and improved methods for detection in clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother (1991) 4.22
Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer (1982) 3.82
Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the Steris System 1 processor. Infect Control Hosp Epidemiol (2001) 2.84
Nosocomial infection caused by gentamicin-resistant, streptomycin-sensitive Klebsiella. J Infect Dis (1975) 2.66
SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob Agents Chemother (1995) 2.66
Fungal endocarditis: analysis of 24 cases and review of the literature. Medicine (Baltimore) (1975) 2.61
Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis (1993) 2.47
Bactericidal and bacteriostatic action of chloramphenicol against memingeal pathogens. Antimicrob Agents Chemother (1979) 2.43
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys (2000) 2.33
Antibiotic combinations: the clinical relevance of synergy and antagonism. Medicine (Baltimore) (1978) 2.33
Treatment of bacterial endocarditis with cephalothin. N Engl J Med (1968) 2.12
Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use. J Infect Dis (1985) 1.92
Partial purification and characterization of human gamma (immune) interferon. Proc Natl Acad Sci U S A (1981) 1.91
Failure of tuberculosis control. A prescription for change. JAMA (1994) 1.82
EFG1 is a major regulator of cell wall dynamics in Candida albicans as revealed by DNA microarrays. Mol Microbiol (2003) 1.79
Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother (1994) 1.67
In vitro bactericidal effectiveness of four aminoglycoside antibiotics. Antimicrob Agents Chemother (1973) 1.64
Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis (1984) 1.62
Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS. J Infect Dis (1989) 1.60
Liposomal amphotericin-B (AmBisome) for treatment of disseminated fungal infections in two infants of very low birth weight. Pediatrics (1992) 1.48
Thrombocytopenia and symmetrical peripheral gangrene associated with staphylococcal and streptococcal bacteremia. Ann Intern Med (1968) 1.46
Impact of nodal status on indication for adjuvant treatment in clinically node negative breast cancer. Istituto Nazionale per lo Studio e las Cura dei Tumori. Ann Oncol (2000) 1.46
Coxsackievirus and adenovirus infection. Association with acute febrile and juvenile rheumatoid arthritis. JAMA (1976) 1.45
Resistance of Staphylococcus aureus to semisynthetic penicillins and cephalothin. J Infect Dis (1977) 1.45
Human immunodeficiency virus infection care is unavailable to inmates on release from jail. Arch Fam Med (1994) 1.43
Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin. J Antimicrob Chemother (1996) 1.40
Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults. Antimicrob Agents Chemother (1982) 1.39
Purification of two subspecies of human gamma (immune) interferon. Proc Natl Acad Sci U S A (1982) 1.37
Molecular weight of human gamma interferon is similar to that of other human interferons. Science (1982) 1.36
Upper respiratory tract carriage of gram-negative enteric bacilli by hospital personnel. JAMA (1970) 1.34
Gentamicin and ampicillin in human bile. J Infect Dis (1971) 1.33
Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes. J Lab Clin Med (1976) 1.31
Allogeneic hematopoietic SCT for patients with autoimmune diseases. Bone Marrow Transplant (2009) 1.28
Maintenance amphotericin B for cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med (1988) 1.25
Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy. J Infect Dis (2001) 1.21
Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients. Bone Marrow Transplant (2008) 1.17
R factors in gentamicin-resistant organisms causing hospital infection. Lancet (1975) 1.16
Subacute and acute endocarditis due to Pseudomonas cepacia in heroin addicts. Am J Med (1975) 1.16
Tissue penetration of amphotericin B in Candida endocarditis. Chest (1974) 1.16
Host defense and antimicrobial therapy in adult gram-negative bacillary meningitis. Ann Intern Med (1982) 1.16
Prognostic significance of DNA di-tetraploidy in neuroblastoma. Med Pediatr Oncol (2001) 1.15
Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae. Clin Infect Dis (1999) 1.15
Relationship of staphylococcal tolerance, teichoic acid antibody, and serum bactericidal activity to therapeutic outcome in Staphylococcus aureus bacteremia. Am J Med (1986) 1.15
Construction and characterization of a bovine BAC library with four genome-equivalent coverage. Genet Sel Evol (2001) 1.14
Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci. Antimicrob Agents Chemother (1986) 1.14
Combined intrathecal and intramuscular gentamicin for gram-negative meningitis. Pharmacologic study of 21 patients. N Engl J Med (1974) 1.13
Acute and subacute endocarditis due to Erysipelothrix rhusopathiae. Am J Med Sci (1973) 1.13
Treatment of gram-negative bacillary meningitis in adults. Ann Intern Med (1972) 1.13
European Nutrition and Health Report 2009. Ann Nutr Metab (2009) 1.13
Polymyxin B-Resistant Acinetobacter baumannii Clinical Isolate Susceptible to Recombinant BPI and Cecropin P1. Antimicrob Agents Chemother (2001) 1.10
Noncytotoxic drug therapy in children with unresectable desmoid tumors. Cancer (1997) 1.09
Nephron-sparing procedures in 11 patients with Wilms' tumor. Pediatr Surg Int (2003) 1.07
Autologous and allogeneic MLC-reactivity in patients with rheumatoid arthritis. J Clin Lab Immunol (1981) 1.05
Granzyme B-induced cell death exerted by ex vivo CTL: discriminating requirements for cell death and some of its signs. Cell Death Differ (2007) 1.03
European Nutrition and Health Report 2009. Forum Nutr (2009) 1.03
Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors. Ann Oncol (2007) 1.02
Two-stage tricuspid valve replacement for mixed bacterial endocarditis. Arch Intern Med (1974) 0.99
Life-threatening Mycoplasma pneumoniae pneumonia. JAMA (1974) 0.99
Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis with intravenous meropenem and intraventricular polymyxin B: case report and review. Clin Infect Dis (1999) 0.99
Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties. Bone Marrow Transplant (2007) 0.98
Mycobacterium tuberculosis specimen contamination revisited: the role of laboratory environmental control in a pseudo-outbreak. Infect Control Hosp Epidemiol (1998) 0.98
Penicillin sensitive nutritionally variant streptococcal endocarditis: relapse after penicillin therapy. Am J Med Sci (1983) 0.98
Granulomatous amebic encephalitis in a child with acute lymphoblastic leukemia successfully treated with multimodal antimicrobial therapy and hyperbaric oxygen. J Clin Microbiol (2010) 0.96
Comparative effects of purified staphylococcal alpha and delta toxins on mitochondrial metabolism. J Infect Dis (1972) 0.96
Biochemical effects of cholera enterotoxin: oxidative metabolism in the infant rabbit. Am J Physiol (1970) 0.95
Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum Genet (1995) 0.95
Efficacy of a twelve-hourly ceftriaxone regimen in the treatment of serious bacterial infections. Antimicrob Agents Chemother (1982) 0.94
Editing does not exist for mammalian selenocysteine tRNAs. Nucleic Acids Res (1993) 0.93
Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus. Klin Padiatr (2012) 0.92
Staphylococcus aureus colonization in intravenous drug abusers, dialysis patients, and diabetics. J Infect Dis (1987) 0.92
Prospective evaluation of late effects after childhood cancer therapy with a follow-up over 9 years. Eur J Pediatr (2000) 0.92
Comparative bactericidal activity of penicillin-netilmicin and penicillin-gentamicin against enterococci. J Antimicrob Chemother (1986) 0.91
Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: raphé control of somatodendritic and terminal 5-HT release. J Neural Transm (Vienna) (1996) 0.90
Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. Leukemia (2005) 0.89
Pseudomonas cepacia tricuspid endocarditis: treatment with trimethoprim, sulfonamide, and polymyxin B. J Infect Dis (1973) 0.89
The use of gentamicin in peritoneal dialysis. I. Pharmacologic results. J Infect Dis (1971) 0.89
Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia. Leukemia (2007) 0.89
Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression. J Virol (1999) 0.88
Acinetobacter. Semin Respir Crit Care Med (2000) 0.88
Procalcitonin and C-reactive protein do not discriminate between febrile reaction to anti-T-lymphocyte antibodies and Gram-negative sepsis. Bone Marrow Transplant (2003) 0.88
Moxalactam therapy for gram-negative bacillary meningitis. Rev Infect Dis (1983) 0.87
Ceftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa. J Antimicrob Chemother (1983) 0.87
Synergy between cephalosporin and aminoglycoside antibiotics against Providencia and Proteus. Antimicrob Agents Chemother (1974) 0.87
Quinupristin/dalfopristin (RP 59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: case report. Microb Drug Resist (1995) 0.87